Interaction between cigarette smoking and high-sensitivity C-reactive protein in the development of coronary vasospasm in patients without hemodynamically significant coronary artery disease

American Journal of the Medical Sciences

Volumn 338, Issue 6, 2009, Pages 440-446

  Hung, Ming Yow ^a,b   Hsu, Kuang Hung ^c   Hung, Ming Jui ^b,d   Cheng, Chi Wen ^d   Kuo, Li Tang ^d   Cherng, Wen Jin ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

C reactive protein; Coronary vasospasm; Inflammation; Interaction; Smoking

Indexed keywords

C REACTIVE PROTEIN; DILTIAZEM; GLYCERYL TRINITRATE; METHYLERGOMETRINE; METHYLERGOMETRINE MALEATE; MILLISTROL; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; ELECTROCARDIOGRAM; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; AGED; BLOOD; CASE CONTROL STUDY; ELECTROCARDIOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SMOKING; TAIWAN;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VASOSPASM; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TAIWAN;

EID: 73949096417     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181b9147f     Document Type: Article

References (37)

1. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-958
2. Vlietstra RE, Kronmal RA, Frye RL, et al. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis 1982;2:208-215
3. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-79
4. Yamaguchi H, Homma Y, Handa S. Biochemical markers of vasospastic coronary artery disease. Nutr Metab Cardiovasc Dis 2003;13: 365-371
5. Miyao Y, Kugiyama K, Kawano H, et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 2000;36:432-437
6. Kugiyama K, Ohgushi M, Motoyama T, et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997;30:920-926
7. Takagi S, Goto Y, Hirose E, et al. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation? Circ J 2004;68:17-22.
8. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397
9. Musunuru K, Kral BG, Blumenthal RS, et al. The use of highsensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med 2008;5:621-635
10. Hung MJ, Cherng WJ, Yang NI, et al. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 2005;96:1484-1490
11. Itoh T, Mizuno Y, Harada E, et al. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007;71:1074-1078
12. Yen ML, Yang CY, Yen BL, et al. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol 2006;110:191-198
13. Baim DS, Grossman W. Coronary angiography. In: Baim DS, Grossman W, editors. Grossman's cardiac catheterization, angiography, and intervention, 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000. p. 249.
14. Hung MJ, Hung MY, Cheng CW, et al. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes. Am J Med Sci 2007;334:160-167
15. Caralis DG, Deligonul U, Kern MJ, et al. Smoking is a risk factor for coronary spasm in young women. Circulation 1992;85:905-909
16. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976;37:269-282
17. Anonymous. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling projct research group. J Chronic Dis 1978;31:201-306.
18. Robertson TL, Kato H, Gordon T, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol 1977;39:244-249 (Pubitemid 8043841)
19. Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004; 109:837-842
20. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279: 1477-1482
21. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
22. Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 1998;46:391-395
23. Kuller LH, Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;144: 537-547
24. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733
25. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843
26. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-1127
27. Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89:419-424
28. Tracy RP. Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly. Am J Geriatr Cardiol 2002;11:93-100, 107.
29. Bhatia V, Chaudhuri A, Tomar R, et al. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 2006;29:2289-2294
30. Murase Y, Yamada Y, Hirashiki A, et al. Genetic risk and geneenvironment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004;25:970-977
31. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985;153:9-13.
32. Ledue TB, Weiner DL, Sipe JD, et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998;35:745-753
33. Erlandsen EJ, Randers E. Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay. Scand J Clin Lab Invest 2000;60:37-43.
34. Ishikawa T, Imamura T, Hatakeyama K, et al. Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation. Am J Cardiol 2004;93: 611-614
35. Maseri A, Severi S, Nes MD, et al. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol 1978;42:1019-1035
36. Dandona P. Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein. Mayo Clin Proc 2008;83:333-342
37. Ridker PM, Danielson E, Fonseca FA, et al; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207